688117.SH
圣诺生物
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 24.20
−6.17%Margins
Gross margin
58.7%
EBITDA margin
32.4%
EBIT margin
27.6%
Net margin
22.1%
FCF margin
1.9%
15.8%
Return on equity
8.8%
Return on assets
13.7%
Return on invested capital
0.41x
Asset turnover
CNY 147.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026